| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA Helicases | 2 | 2022 | 104 | 1.460 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 3 | 2018 | 185 | 1.450 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 3 | 2023 | 466 | 1.260 |
Why?
|
| Receptors, Androgen | 4 | 2023 | 854 | 1.120 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2023 | 2073 | 1.080 |
Why?
|
| Mammary Neoplasms, Animal | 2 | 2018 | 236 | 1.010 |
Why?
|
| Prostatic Neoplasms | 10 | 2022 | 5867 | 1.010 |
Why?
|
| Inflammation | 5 | 2022 | 2518 | 0.940 |
Why?
|
| 3-Phosphoinositide-Dependent Protein Kinases | 1 | 2023 | 40 | 0.890 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2023 | 669 | 0.880 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2022 | 16 | 0.840 |
Why?
|
| Prostate | 6 | 2014 | 1089 | 0.830 |
Why?
|
| Keto Acids | 1 | 2022 | 58 | 0.830 |
Why?
|
| Guanidines | 1 | 2022 | 61 | 0.820 |
Why?
|
| GATA2 Transcription Factor | 1 | 2022 | 67 | 0.820 |
Why?
|
| Transaminases | 1 | 2022 | 82 | 0.810 |
Why?
|
| Co-Repressor Proteins | 1 | 2021 | 120 | 0.760 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2021 | 162 | 0.740 |
Why?
|
| Lipopolysaccharides | 1 | 2022 | 589 | 0.690 |
Why?
|
| Stromal Cells | 6 | 2014 | 826 | 0.680 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2023 | 1710 | 0.630 |
Why?
|
| Alpharetrovirus | 1 | 2018 | 7 | 0.610 |
Why?
|
| Gene Transfer Techniques | 2 | 2018 | 804 | 0.590 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2022 | 875 | 0.570 |
Why?
|
| Transforming Growth Factor beta | 4 | 2014 | 1109 | 0.570 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 269 | 0.560 |
Why?
|
| MAP Kinase Signaling System | 1 | 2021 | 885 | 0.540 |
Why?
|
| Retroviridae | 1 | 2017 | 373 | 0.540 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 2014 | 225 | 0.510 |
Why?
|
| Neoplasms | 5 | 2023 | 15933 | 0.450 |
Why?
|
| Gene Expression Regulation, Neoplastic | 10 | 2023 | 9042 | 0.400 |
Why?
|
| Mice | 18 | 2022 | 35598 | 0.390 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2022 | 1388 | 0.380 |
Why?
|
| T-Lymphocytes | 1 | 2022 | 3944 | 0.340 |
Why?
|
| Animals | 21 | 2022 | 62051 | 0.320 |
Why?
|
| Cell Line, Tumor | 9 | 2023 | 14841 | 0.310 |
Why?
|
| Androgens | 3 | 2023 | 508 | 0.310 |
Why?
|
| Mice, SCID | 2 | 2022 | 1825 | 0.290 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2007 | 241 | 0.280 |
Why?
|
| Immediate-Early Proteins | 1 | 2005 | 105 | 0.250 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2022 | 1013 | 0.230 |
Why?
|
| Signal Transduction | 5 | 2023 | 12103 | 0.230 |
Why?
|
| Proteins | 4 | 2014 | 2043 | 0.220 |
Why?
|
| Androgen Antagonists | 2 | 2023 | 420 | 0.210 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2017 | 2453 | 0.210 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2022 | 22 | 0.210 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2005 | 659 | 0.200 |
Why?
|
| Micrococcal Nuclease | 1 | 2001 | 12 | 0.200 |
Why?
|
| Staphylococcus | 1 | 2001 | 98 | 0.190 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2021 | 271 | 0.180 |
Why?
|
| Kupffer Cells | 1 | 2020 | 41 | 0.170 |
Why?
|
| Protein Isoforms | 1 | 2022 | 848 | 0.170 |
Why?
|
| Th1 Cells | 1 | 2021 | 259 | 0.170 |
Why?
|
| Protein Conformation | 3 | 2003 | 1255 | 0.170 |
Why?
|
| Mice, Knockout | 3 | 2021 | 5731 | 0.170 |
Why?
|
| Th17 Cells | 1 | 2021 | 163 | 0.170 |
Why?
|
| Receptors, Calcitriol | 1 | 2020 | 140 | 0.160 |
Why?
|
| Hepatitis | 1 | 2020 | 92 | 0.160 |
Why?
|
| Mass Spectrometry | 1 | 2001 | 722 | 0.160 |
Why?
|
| Cell Line | 4 | 2021 | 5339 | 0.160 |
Why?
|
| Serine Endopeptidases | 2 | 2014 | 275 | 0.150 |
Why?
|
| Humans | 21 | 2023 | 270880 | 0.150 |
Why?
|
| Reactive Oxygen Species | 1 | 2022 | 1006 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 5 | 2020 | 7103 | 0.140 |
Why?
|
| Ribosomes | 1 | 1997 | 168 | 0.140 |
Why?
|
| Breast Neoplasms | 2 | 2022 | 16212 | 0.140 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2022 | 1585 | 0.140 |
Why?
|
| HEK293 Cells | 1 | 2021 | 1462 | 0.140 |
Why?
|
| Luciferases | 1 | 1997 | 460 | 0.140 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2021 | 714 | 0.140 |
Why?
|
| Transforming Growth Factor beta1 | 4 | 2014 | 294 | 0.130 |
Why?
|
| Calcium | 1 | 2022 | 1589 | 0.130 |
Why?
|
| Cell Survival | 1 | 2022 | 3065 | 0.130 |
Why?
|
| Carcinoma | 1 | 2007 | 2609 | 0.130 |
Why?
|
| Cysteine Endopeptidases | 1 | 2017 | 262 | 0.130 |
Why?
|
| Endopeptidases | 1 | 2017 | 230 | 0.130 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1032 | 0.130 |
Why?
|
| Transplantation, Heterologous | 3 | 2007 | 1054 | 0.130 |
Why?
|
| Male | 15 | 2023 | 128463 | 0.130 |
Why?
|
| Mitochondria | 1 | 2022 | 1299 | 0.130 |
Why?
|
| Bone Morphogenetic Protein 6 | 1 | 2014 | 13 | 0.120 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2022 | 1564 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 3 | 2014 | 5759 | 0.120 |
Why?
|
| Pteridines | 1 | 2014 | 35 | 0.120 |
Why?
|
| Neoplasm Metastasis | 2 | 2017 | 5310 | 0.120 |
Why?
|
| Disease Models, Animal | 4 | 2021 | 7386 | 0.120 |
Why?
|
| Oncogenes | 1 | 2018 | 700 | 0.120 |
Why?
|
| Kallikreins | 1 | 2014 | 86 | 0.120 |
Why?
|
| Insulin Resistance | 1 | 2020 | 732 | 0.120 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2020 | 444 | 0.120 |
Why?
|
| Myofibroblasts | 1 | 2014 | 98 | 0.110 |
Why?
|
| Mice, Nude | 5 | 2014 | 4329 | 0.110 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2022 | 3919 | 0.110 |
Why?
|
| Sequence Deletion | 1 | 2017 | 909 | 0.110 |
Why?
|
| Phenylthiohydantoin | 1 | 2014 | 104 | 0.110 |
Why?
|
| DNA Repair | 1 | 2021 | 1910 | 0.110 |
Why?
|
| Microarray Analysis | 1 | 2014 | 397 | 0.110 |
Why?
|
| DNA Damage | 1 | 2021 | 1988 | 0.110 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2014 | 214 | 0.110 |
Why?
|
| Mice, Inbred ICR | 1 | 2013 | 244 | 0.100 |
Why?
|
| Neovascularization, Pathologic | 4 | 2007 | 1585 | 0.100 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2017 | 1002 | 0.100 |
Why?
|
| Mice, Transgenic | 3 | 2017 | 4224 | 0.090 |
Why?
|
| In Situ Hybridization | 1 | 2013 | 1050 | 0.090 |
Why?
|
| beta Catenin | 1 | 2015 | 683 | 0.090 |
Why?
|
| Ganglia | 1 | 2010 | 25 | 0.090 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 1199 | 0.090 |
Why?
|
| Prostate-Specific Antigen | 1 | 2014 | 1029 | 0.090 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2015 | 619 | 0.090 |
Why?
|
| Interleukin-6 | 1 | 2014 | 1051 | 0.090 |
Why?
|
| Nitriles | 1 | 2014 | 939 | 0.080 |
Why?
|
| Wound Healing | 1 | 2014 | 768 | 0.080 |
Why?
|
| Benzamides | 1 | 2014 | 1879 | 0.080 |
Why?
|
| Disease Progression | 2 | 2013 | 6865 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2014 | 3588 | 0.080 |
Why?
|
| Carcinogenesis | 1 | 2015 | 1033 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 3604 | 0.080 |
Why?
|
| 3T3 Cells | 2 | 2005 | 384 | 0.080 |
Why?
|
| Macrophages | 1 | 2014 | 1352 | 0.080 |
Why?
|
| Immunotherapy | 1 | 2021 | 3557 | 0.070 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2007 | 227 | 0.070 |
Why?
|
| Protein Biosynthesis | 2 | 2003 | 1028 | 0.070 |
Why?
|
| RNA, Messenger | 2 | 2014 | 6398 | 0.070 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2005 | 43 | 0.060 |
Why?
|
| Liver | 1 | 2015 | 3088 | 0.060 |
Why?
|
| Apoptosis | 2 | 2017 | 7754 | 0.060 |
Why?
|
| Female | 3 | 2022 | 149029 | 0.060 |
Why?
|
| Muramidase | 1 | 2003 | 113 | 0.050 |
Why?
|
| Antigen-Antibody Complex | 1 | 2003 | 122 | 0.050 |
Why?
|
| TNF Receptor-Associated Factor 4 | 1 | 2023 | 24 | 0.050 |
Why?
|
| HIV-1 | 1 | 2007 | 639 | 0.050 |
Why?
|
| Aging | 1 | 2010 | 1551 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2007 | 1052 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2014 | 7237 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2013 | 9290 | 0.050 |
Why?
|
| Hydrolysis | 1 | 2001 | 237 | 0.050 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2001 | 206 | 0.050 |
Why?
|
| Protein Structure, Secondary | 1 | 2001 | 338 | 0.050 |
Why?
|
| Binding Sites | 2 | 2003 | 2256 | 0.050 |
Why?
|
| Ubiquitination | 1 | 2023 | 579 | 0.040 |
Why?
|
| Radioimmunotherapy | 1 | 2021 | 128 | 0.040 |
Why?
|
| Models, Molecular | 2 | 2003 | 1742 | 0.040 |
Why?
|
| Tumor Microenvironment | 2 | 2021 | 3031 | 0.040 |
Why?
|
| Macrophage Activation | 1 | 2020 | 151 | 0.040 |
Why?
|
| Autoimmunity | 1 | 2021 | 267 | 0.040 |
Why?
|
| Ligands | 1 | 2001 | 1016 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 3478 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2001 | 1472 | 0.040 |
Why?
|
| Coleoptera | 1 | 1997 | 19 | 0.040 |
Why?
|
| Vitamin D | 1 | 2020 | 261 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1997 | 631 | 0.030 |
Why?
|
| Protein Stability | 1 | 2017 | 377 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 1997 | 657 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2017 | 589 | 0.030 |
Why?
|
| Cell Division | 2 | 2014 | 2657 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2017 | 895 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 1997 | 1431 | 0.030 |
Why?
|
| Protein Binding | 1 | 2001 | 3485 | 0.030 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2014 | 70 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 12027 | 0.030 |
Why?
|
| Osteopontin | 1 | 2014 | 145 | 0.030 |
Why?
|
| Fibronectins | 1 | 2014 | 205 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2014 | 350 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2017 | 7665 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2014 | 628 | 0.030 |
Why?
|
| Cellular Senescence | 1 | 2015 | 389 | 0.030 |
Why?
|
| Cell Movement | 2 | 2014 | 2472 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 1997 | 3029 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2014 | 1028 | 0.020 |
Why?
|
| Organoids | 1 | 2014 | 332 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2014 | 701 | 0.020 |
Why?
|
| Escherichia coli | 1 | 1997 | 1305 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2014 | 968 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2003 | 4480 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 1997 | 3341 | 0.020 |
Why?
|
| Phenotype | 1 | 2021 | 6516 | 0.020 |
Why?
|
| Genetic Variation | 1 | 1997 | 2166 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 2196 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 1496 | 0.020 |
Why?
|
| Time Factors | 1 | 2001 | 13023 | 0.020 |
Why?
|
| Obesity | 1 | 2020 | 2905 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2007 | 827 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2007 | 593 | 0.010 |
Why?
|
| Base Sequence | 1 | 2010 | 5437 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2014 | 4117 | 0.010 |
Why?
|
| Hydrogen Bonding | 1 | 2003 | 134 | 0.010 |
Why?
|
| CHO Cells | 1 | 2003 | 320 | 0.010 |
Why?
|
| COS Cells | 1 | 2003 | 417 | 0.010 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2003 | 104 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 5149 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2014 | 3346 | 0.010 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2003 | 172 | 0.010 |
Why?
|
| Cricetinae | 1 | 2003 | 769 | 0.010 |
Why?
|
| Chickens | 1 | 2003 | 783 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 2003 | 286 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2015 | 3657 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2015 | 2175 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2003 | 329 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 2003 | 635 | 0.010 |
Why?
|
| Protein Precursors | 1 | 2002 | 249 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2003 | 1554 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2021 | 33756 | 0.010 |
Why?
|
| Antibodies | 1 | 2002 | 809 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2007 | 5698 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2015 | 4820 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2002 | 1309 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 7915 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 6686 | 0.010 |
Why?
|
| Young Adult | 1 | 2014 | 22245 | 0.010 |
Why?
|
| Mutation | 1 | 2015 | 15911 | 0.010 |
Why?
|
| Adult | 1 | 2014 | 82036 | 0.000 |
Why?
|